Prime Medicine, Inc. (NYSE:PRME) Receives $13.13 Average Target Price from Brokerages
Prime Medicine, Inc. (NYSE:PRME – Get Free Report) has been assigned an average rating of “Buy” from the ten research firms that are currently covering the stock, MarketBeat reports. Nine analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year target […]
Prime Medicine, Inc. (NYSE:PRME – Get Free Report) has been assigned an average rating of “Buy” from the ten research firms that are currently covering the stock, MarketBeat reports. Nine analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year target […]
